These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12819489)

  • 1. Effects of immunosuppressive drugs on dendritic cells and tolerance induction.
    Lagaraine C; Lebranchu Y
    Transplantation; 2003 May; 75(9 Suppl):37S-42S. PubMed ID: 12819489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immunosuppressive drugs on dendritic cells.
    Abe M; Thomson AW
    Transpl Immunol; 2003; 11(3-4):357-65. PubMed ID: 12967788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing dendritic cells for the induction of transplantation tolerance.
    Silk KM; Fairchild PJ
    Curr Opin Organ Transplant; 2009 Aug; 14(4):344-50. PubMed ID: 19417656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting dendritic cells for priming cellular immune responses.
    Gogolák P; Réthi B; Hajas G; Rajnavölgyi E
    J Mol Recognit; 2003; 16(5):299-317. PubMed ID: 14523943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of rapamycin in the induction of tolerogenic dendritic cells.
    Fischer R; Turnquist HR; Taner T; Thomson AW
    Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance.
    Kim YS; Yang SH; Kang HG; Seong EY; Lee SH; Gao W; Kenny J; Zheng XX; Strom TB
    Int Immunol; 2006 Dec; 18(12):1771-7. PubMed ID: 17068105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ; O'Neill HC
    Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells.
    Cicinnati VR; Hou J; Lindemann M; Horn PA; Sotiropoulos GC; Paul A; Gerken G; Beckebaum S
    Transplantation; 2009 Aug; 88(4):504-13. PubMed ID: 19696633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs.
    Hackstein H; Thomson AW
    Nat Rev Immunol; 2004 Jan; 4(1):24-34. PubMed ID: 14704765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors.
    Tha-In T; Metselaar HJ; Tilanus HW; Boor PP; Mancham S; Kuipers EJ; de Man RA; Kwekkeboom J
    Transplantation; 2006 Jun; 81(12):1725-34. PubMed ID: 16794540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological concentrations of transforming growth factor beta1 selectively inhibit human dendritic cell function.
    Fogel-Petrovic M; Long JA; Misso NL; Foster PS; Bhoola KD; Thompson PJ
    Int Immunopharmacol; 2007 Dec; 7(14):1924-33. PubMed ID: 18039529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of antigen-presenting cell functions by alcohol: implications for hepatitis C virus infection.
    Szabo G; Dolganiuc A; Mandrekar P; White B
    Alcohol; 2004 Jul; 33(3):241-9. PubMed ID: 15596093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of human CD4+ regulatory T cells by mycophenolic acid-treated dendritic cells.
    Lagaraine C; Lemoine R; Baron C; Nivet H; Velge-Roussel F; Lebranchu Y
    J Leukoc Biol; 2008 Oct; 84(4):1057-64. PubMed ID: 18611986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicubenol and Ferruginol induce DC from human monocytes and differentiate IL-10-producing regulatory T cells in vitro.
    Takei M; Umeyama A; Arihara S
    Biochem Biophys Res Commun; 2005 Nov; 337(2):730-8. PubMed ID: 16202980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?
    Steinbrink K; Mahnke K; Grabbe S; Enk AH; Jonuleit H
    Hum Immunol; 2009 May; 70(5):289-93. PubMed ID: 19217922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine.
    Popov I; Li M; Zheng X; San H; Zhang X; Ichim TE; Suzuki M; Feng B; Vladau C; Zhong R; Garcia B; Strejan G; Inman RD; Min WP
    Arthritis Res Ther; 2006; 8(5):R141. PubMed ID: 16911769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulatory role of dendritic cells in the immune tolerance.
    Li YP; Latger-Canard V; Marchal L; Li N; Ou-Yang JP; Stoltz JF
    Biomed Mater Eng; 2006; 16(4 Suppl):S163-70. PubMed ID: 16823108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.
    Li M; Zhang X; Zheng X; Lian D; Zhang ZX; Sun H; Suzuki M; Vladau C; Huang X; Xia X; Zhong R; Garcia B; Min WP
    Int Immunol; 2008 Feb; 20(2):285-93. PubMed ID: 18182381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.